Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
02/2006
02/01/2006CN1239484C Process for preparing 4-substituted pyridine compound
02/01/2006CN1239472C HIV integrase inhibitors
01/2006
01/31/2006US6992190 Hydroxamic acid derivatives as antibacterials
01/31/2006US6992104 C7 carbonate taxane compositions
01/31/2006US6992098 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination
01/31/2006US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof
01/31/2006US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders
01/31/2006US6991857 Metal coordination compound, luminescence device and display apparatus
01/31/2006CA2186991C Process for the preparation of acyl isocyanates
01/26/2006WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
01/26/2006WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
01/26/2006WO2006009054A1 Phenethylnicotinamide compound
01/26/2006WO2006008635A1 Process for the preparation of a 3-phenoxy-pyridine derivative
01/26/2006WO2006008191A1 3-pyridinylethylbenzamide derivatives as fungicides
01/26/2006WO2006007912A1 Method for producing onium salts with a low chloride content
01/26/2006WO2005110982A3 Substituted 1-benzyl-4-substituted piperazine analogues
01/26/2006WO2005105766A3 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
01/26/2006WO2005061476A3 Aroylfuranes and aroylthiophenes
01/26/2006WO2001085170A9 Peptide deformylase inhibitors
01/26/2006US20060020135 Long chain aliphatic alcohol derivatives and methods of making and using same
01/26/2006US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
01/26/2006US20060020039 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-fluorophenoxy)1-aminoisoquinoline; and 3-(2-(4-[(2-aminosulfonyl)phenyl]phenylaminocarbonyl-4-chlorophenoxy)benzamidine; highly selective
01/26/2006US20060020009 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
01/26/2006US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
01/26/2006US20060019962 Modulators of muscarinic receptors
01/26/2006US20060019565 Method for delivering biologically active substnces
01/26/2006DE10223908B4 Verfahren zur Herstellung von substituierten Pyridinen A process for the preparation of substituted pyridines
01/26/2006CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
01/26/2006CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
01/26/2006CA2573746A1 Process for the preparation of onium salts having a low chloride content
01/26/2006CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1619184A2 Urea compounds as kinase inhibitors
01/25/2006EP1618087A2 Antibacterial agents
01/25/2006EP1617946A1 Ti-pillared clay based vandia catalyst and process for preparation
01/25/2006EP1446224B1 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006CN1726603A Charge transport compositions and electronic devices made with such compositions
01/25/2006CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
01/25/2006CN1726200A Ionic liquids comprising [N(CF3)2] anions
01/25/2006CN1726197A 5-substituted-pyrazine or -pyridine glucokinase activators
01/25/2006CN1726193A Heterocyclic selective androgen receptor modulators and methods of use thereof
01/25/2006CN1724523A Long chain aromatic piperazine modified 2-(arylthio) benzylamin derivative and its preparation method and applicaltion
01/25/2006CN1238565C Selective electrochemical reduction of halogenated 4-aminopicolinic acids
01/25/2006CN1238340C Alkylthio-and aryl (heteroyl) thio substituted p-phenylenediamines their manufacture and their use in rubber
01/25/2006CN1238337C Pesticide
01/25/2006CN1237969C Remedial agent for chronic articular rheumatism
01/24/2006US6989468 Oxoperoxotungsten(VI) complex catalysts
01/24/2006US6989448 Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
01/24/2006US6989402 Thyroid receptor ligands and method II
01/24/2006US6989398 Benzanilides as potassium channel openers
01/24/2006US6989397 Iron chelators and uses thereof
01/24/2006US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
01/24/2006US6989382 Enzyme inhibitors; pyridin-2-yl-amino-ethyl-amino-phenyl derivatives; diabetes, Alzheimer's disease, Parkinson's disease, Huntington's disease, obesity, cardiovascular disease, hypertension, polycystic ovary syndrome, ischemia, brain injury
01/24/2006US6989139 Matrix metalloproteinase inhibitors
01/24/2006CA2347117C Methods for inhibiting diabetic complications
01/19/2006WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor
01/19/2006WO2006005909A1 Substituted acids for the treatment of respiratory diseases
01/19/2006WO2006005548A1 Novel 2,6-diaminopyridine-3-one derivatives
01/19/2006WO2005097746A3 2-propene-1-ones as hsp 70 inducers
01/19/2006US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
01/19/2006US20060014960 Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides
01/19/2006US20060014959 Process for preparation of pyridine derivatives of NK-1 receptor antagonist
01/19/2006US20060014955 Optically enhanced chiral ionic liquids
01/19/2006US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus
01/19/2006US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
01/19/2006US20060014827 3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
01/19/2006US20060014806 Dihalo-allyloxy-phenol derivatives having pesticidal activity
01/19/2006US20060014804 Cyanoguanidine prodrugs
01/19/2006US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
01/19/2006US20060014788 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
01/19/2006US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/19/2006US20060014783 Sulfonylamino-acetic acid derivatives
01/19/2006US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors
01/19/2006US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders
01/19/2006US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/19/2006US20060014047 Luminescence device, display apparatus and metal coordination compound
01/19/2006DE19748440B4 6,7-Difluor-1,2,3,4-tetrahydronaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen, diese enthaltende Flüssigkristallmischungen sowie ferroelektrische Schalt- und/oder Anzeigevorrichtungen 6,7-difluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid crystalline mixtures, liquid crystal mixtures containing them, as well as ferroelectric switching and / or display devices
01/19/2006DE102004030163A1 Verfahren zur Reinigung von Nicotinsäure A process for the purification of nicotinic acid
01/19/2006CA2573604A1 Novel 2,6-diaminopyridine-3-one derivatives
01/19/2006CA2573243A1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives
01/18/2006EP1616867A1 Hydroxycarboxylic acid derivatives
01/18/2006EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
01/18/2006EP1616863A1 Process for the preparation of fluorinated aromatic compounds
01/18/2006EP1616862A1 Nitrogenous heterocyclic compound and use thereof
01/18/2006EP1616859A1 Substituted cyclohexyl carboxylic acid compounds
01/18/2006EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors
01/18/2006EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators
01/18/2006EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615891A1 Method for the production of nicotinaldehydes
01/18/2006EP1615878A2 Compounds, compositions and methods
01/18/2006EP1615866A1 Indene derivatives as pharmaceutical agents
01/18/2006EP1615629A1 Peptide deformylase inhibitors
01/18/2006EP1292590B1 Admantane derivatives
01/18/2006EP1200420B1 Process for making n-alkyl bis(thiazolyl)sulfenimides
01/18/2006EP0973727B8 Activated iododerivatives for the treatment of cancer and aids